SFG
DTIL icon

Steward Financial Group’s Precision BioSciences DTIL Stock Holding History

Steward Financial Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed – – 776
2022
Q4 		$0 Buy
+3
New +$119 ﹤0.01% 614
2022
Q3 		– Sell
-3
Closed – – 435
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1072
2022
Q1 		$0 Hold
3
– – ﹤0.01% 324
2021
Q4 		$0 Buy
+3
New +$838 ﹤0.01% 267

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Steward Financial Group's DTIL Position: Q1 2023 in Review

Steward Financial Group sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 3 shares.

Steward Financial Group first reported a position in DTIL in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q4 2022. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • Steward Financial Group reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • Steward Financial Group sold 3 Precision BioSciences shares in Q1 2023.
  • Steward Financial Group first reported a position in Precision BioSciences in Q4 2021 and held it in 4 quarters.
  • Steward Financial Group's Precision BioSciences position peaked at $0 in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Steward Financial Group's 13F filing for Q1 2023, filed 5 May 2023.